These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16142098)

  • 1. [Correction of facial lipoatrophy with a biodegradable material in HIV-infected patients].
    Carbonnel E; Claudy A
    Ann Dermatol Venereol; 2005; 132(6-7 Pt 1):521-4. PubMed ID: 16142098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE].
    Lafaurie M; Dolivo M; Girard PM; May T; Bouchaud O; Carbonnel E; Madelaine I; Loze B; Porcher R; Molina JM;
    HIV Med; 2013 Aug; 14(7):410-20. PubMed ID: 23432777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study.
    Mole B; Gillaizeau F; Carbonnel E; Pierre I; Brazille P; Grataloup C; Mercier S; Duracinsky M; Weiss L; Piketty C
    AIDS Res Hum Retroviruses; 2012 Mar; 28(3):251-8. PubMed ID: 21801082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy.
    Ramon Y; Fodor L; Ullmann Y
    Dermatology; 2007; 214(2):151-4. PubMed ID: 17341865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.
    Burgess CM; Quiroga RM
    J Am Acad Dermatol; 2005 Feb; 52(2):233-9. PubMed ID: 15692467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year study of a polyacrylamide hydrogel-based filler for rehabilitation of HIV-related facial lipoatrophy.
    Rauso R
    Aesthet Surg J; 2015 Nov; 35(8):1021-9. PubMed ID: 25953480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
    Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
    AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy.
    Cattelan AM; Bauer U; Trevenzoli M; Sasset L; Campostrini S; Facchin C; Pagiaro E; Gerzeli S; Cadrobbi P; Chiarelli A
    Arch Dermatol; 2006 Mar; 142(3):329-34. PubMed ID: 16549708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
    Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
    Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cheek augmentation with Bio-Alcamid in facial lipoatrophy in HIV seropositive patients.
    Hönig J
    J Craniofac Surg; 2008 Jul; 19(4):1085-8. PubMed ID: 18650737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient satisfaction following Bio-Alcamid injection for facial contour defects.
    George DA; Erel E; Waters R
    J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1622-6. PubMed ID: 22749703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy.
    Negredo E; Puig J; Aldea D; Medina M; Estany C; Pérez-Alvarez N; Rodríguez-Fumaz C; Muñoz-Moreno JA; Higueras C; Gonzalez-Mestre V; Clotet B
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):451-5. PubMed ID: 19320569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and color Doppler ultrasound evaluation of polyacrylamide injection in HIV patients with severe facial lipoatrophy secondary to antiretroviral therapy.
    Faundez E; Vega N; Vera E; Vega P; Sepulveda D; Wortsman X
    Skin Res Technol; 2017 May; 23(2):243-248. PubMed ID: 27796065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up.
    De Santis G; Pignatti M; Baccarani A; Pedone A; Spaggiari A; Orlando G; Guaraldi G
    Plast Reconstr Surg; 2012 Jan; 129(1):101-109. PubMed ID: 22186503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyacrylamide gel treatment of antiretroviral therapy-induced facial lipoatrophy in HIV patients.
    Mansor S; Breiting VB; Dahlstrøm K; Andersen AB; Andersen O; Christensen LH
    Aesthetic Plast Surg; 2011 Oct; 35(5):709-16. PubMed ID: 21359981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly-L-lactic acid.
    Perry CM
    Am J Clin Dermatol; 2004; 5(5):361-6; discussion 367-8. PubMed ID: 15554738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.
    Rauso R; Curinga G; Santillo V; Corvo G; Tartaro G
    J Craniofac Surg; 2011 Sep; 22(5):1684-8. PubMed ID: 21959413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated facial lipoatrophy.
    James J; Carruthers A; Carruthers J
    Dermatol Surg; 2002 Nov; 28(11):979-86. PubMed ID: 12460289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients.
    Negredo E; Puig J; Ornelas A; Echeverría P; Bonjoch A; Estany C; Higueras C; Gonzalez-Mestre V; Clotet B
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):817-21. PubMed ID: 25858612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.